Literature DB >> 956876

Clinical and pathological study of 24 cases of gliosarcoma.

R A Morantz, I Feigin, J Ransohoff.   

Abstract

The authors review the clinical and pathological features of 24 patients with gliosarcoma. The study revealed the following findings. Gliosarcoma occurs more frequently than is indicated in the literature, and in our series was present in 8% of all cases of glioblastoma multiforme. The presenting features are not significantly different from those of glioblastoma multiforme. The lesion often presents itself at surgery as a firm, well circumscribed mass within the temporal lobe, and at surgery it is commonly mistaken for a meningioma. There is an increased likelihood of metastasis compared to that of glioblastoma. The prognosis is no worse than that of glioblastoma, in spite of the addition of sarcomatous elements.

Entities:  

Mesh:

Year:  1976        PMID: 956876     DOI: 10.3171/jns.1976.45.4.0398

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  59 in total

1.  Gliosarcoma: A rare primary CNS tumor. Presentation of two cases.

Authors:  José Pardo; Mauricio Murcia; Felip García; Arnaldo Alvarado
Journal:  Rep Pract Oncol Radiother       Date:  2010-07-07

Review 2.  Therapeutic management of gliosarcoma in the temozolomide era.

Authors:  Mary Frances McAleer; Paul D Brown
Journal:  CNS Oncol       Date:  2015-04-23

3.  Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.

Authors:  J Castelli; L Feuvret; Q C Haoming; J Biau; E Jouglar; A Berger; G Truc; F Llamas Gutierrez; X Morandi; P J Le Reste; F Thillays; D Loussouarn; E Nouhaud; G Crehange; D Antoni; E Vauleon; R de Crevoisier; G Noel
Journal:  J Neurooncol       Date:  2016-05-11       Impact factor: 4.130

4.  Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies.

Authors:  F Slowik; K Jellinger; L Gaszó; J Fischer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

5.  GFAP, F VIII/RAg, laminin, and fibronectin in gliosarcomas: an immunohistochemical study.

Authors:  D Schiffer; M T Giordana; A Mauro; A Migheli
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Gliosarcomas: analysis of 11 cases do two subtypes exist?

Authors:  Maurizio Salvati; Emanuela Caroli; Antonino Raco; Felice Giangaspero; Roberto Delfini; Luigi Ferrante
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

7.  Gliosarcoma of the posterior cranial fossa: MRI findings.

Authors:  H Nitta; H Hayase; Y Moriyama; T Yamashima; J Yamashita
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

Review 8.  Gliofibromas (including malignant forms), and gliosarcomas: a comparative study and review of the literature.

Authors:  M Cerda-Nicolas; J J Kepes
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Gliomyosarcoma: an immunohistochemical analysis.

Authors:  S R Stapleton; W Harkness; P R Wilkins; D Uttley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

Review 10.  Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.

Authors:  Seunggu J Han; Isaac Yang; Tarik Tihan; Michael D Prados; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-07-18       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.